Warfarin Use and Risk of Knee and Hip Replacements Priyanka Ballal, MD – Boston University School of Medicine
11:45 AM – 12:00 PM ET
Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Trial of BIIB059, an Anti-Blood Dendritic Cell Antigen 2 Antibody, in SLE Richard Furie, MD – Northwell Health
12:00 PM – 12:15 PM ET
Urine Proteomics and Single Cell Transcriptomics Identify IL-16 as a Biomarker for Lupus Nephritis Andrea Fava, MD – Johns Hopkins University
12:15 PM – 12:30 PM ET
Late Cardiovascular Outcomes in Children with Kawasaki Disease: A Population-based Cohort Study Cal Robinson, MD – The Hospital for Sick Children
12:30 PM – 12:45 PM ET
Low Preconceptional Complement Level Is Related with an Adverse Obstetric Outcome in a Multicentric Cohort of Pregnancy in Patients with APS and aPL Positivity Cecilia Nalli, MD – ASST SPEDALI CIVILI DI BRESCIA
12:45 PM – 1:00 PM ET
Maintenance of Remission After Withdrawal of Etanercept or Methotrexate in Patients with Rheumatoid Arthritis in Sustained Remission on Combination Therapy: Results from a Randomized, Double-blind, Controlled Trial Jeffrey R R. Curtis, MD, MS, MPH – University of Alabama at Birmingham